Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.57% | -56.55% | -55.70% | 100.72% | 225.19% |
| Total Receivables | 49.85% | 42.15% | 50.36% | 46.18% | 185.26% |
| Inventory | 120.18% | 2.66% | -31.98% | -50.83% | -35.90% |
| Prepaid Expenses | -54.37% | -67.55% | -45.54% | 19.61% | 1,141.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 64.47% | 240.99% | 523.60% | 959.09% | 2,630.00% |
| Total Current Assets | -20.53% | -34.39% | -36.96% | 64.29% | 205.95% |
|
|
|||||
| Total Current Assets | -20.53% | -34.39% | -36.96% | 64.29% | 205.95% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 234.41% | 312.74% | 235.42% | 13,600.00% | 1,703.77% |
| Total Assets | -16.39% | -28.95% | -32.94% | 67.31% | 209.65% |
|
|
|||||
| Total Accounts Payable | 51.69% | 33.60% | 1.46% | -14.21% | 31.49% |
| Total Accrued Expenses | 11.71% | -26.76% | -34.84% | -8.68% | 248.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -90.48% | -66.67% |
| Total Finance Division Other Current Liabilities | 0.00% | -1.59% | -1.59% | -- | -- |
| Total Other Current Liabilities | 0.00% | -1.59% | -1.59% | -- | -- |
| Total Current Liabilities | 32.01% | 8.58% | -14.89% | -8.39% | 90.01% |
|
|
|||||
| Total Current Liabilities | 32.01% | 8.58% | -14.89% | -8.39% | 90.01% |
| Long-Term Debt | -39.63% | -39.06% | -38.27% | -37.48% | 25.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -1.73% | -1.73% | 1,227,950.00% | -- |
| Total Liabilities | -16.13% | -18.88% | -21.00% | 32.04% | 116.83% |
|
|
|||||
| Common Stock & APIC | 3.61% | 2.83% | 2.66% | 3.00% | 3.17% |
| Retained Earnings | -3.19% | -5.68% | -6.99% | -0.20% | -0.52% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 13.13% | -449.96% | -295.09% | 49.48% | 50.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.13% | -449.96% | -295.09% | 49.48% | 50.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.13% | -449.96% | -295.09% | 49.48% | 50.90% |
|
|
|||||